Category Archives: Publications and Presentations

Presentations Abstracts

National(*) , Regional(**) or International(***) Research (PA-x)

** 1. Cooper JW, Honigberg IL. Synthesis of Cyclic Amino Acids, Southeastern Medicinal Chemistry Society, Athens, March 1967.

* 2. Cooper JW, Fish K, Wellins I and Loomis M, “A Seven Nursing Home Study of the Incidence of Potential Drug Interactions,”to Academy of General Practice, APhA, August, 1974, Chicago, Illinois, Proceedings.

* 3. Walchle RC, Cooper JW, “Incidence of Potential Drug Related Problems in Patients Entering a Small Community Hospital,” to Academy of General Practice, APhA, August, 1974, Chicago, Illinois, Proceedings.

* 4. Cooper JW, “Continual Clinical Pharmacy I: A Method to Detect Drug Related Problems in the Small Community,” to the American College of Clinical Pharmacology, May, 1975, Atlantic City, NJ

* 5. Cooper JW, Campbell NA, “Community Hospital Practitioner Consultation,” to Academy of General Practice, APhA, July, 1973, Boston, Massachusetts, Proceedings.

* 6. Cooper JW, “Ideas That Work in the LTCF,” American Pharmaceutical Association Annual Meeting, Academy of General Practice, Long Term Care Section, May 17, 1977, New York, New York, Proceedings.

* 7. Lewis KP, Cooper JW, McKercher PL, “Pharmacist Effect on Digoxin Usage and Toxicity,ASHP Mid Year Clinical Meeting, December 8,1976, Anaheim, California, Proceedings. NOTE; KP Lewis was awarded the ASHP Student Research award in 1977

* 8. Walchle RC, McKercher PL, Cooper JW, “Patient Drug Histories by Criterion Selection,ASHP Annual Meeting, May 18, 1977, New York, New York, Proceedings.

* 9. Birmingham BK, Rhodes CT, Green DS, Cooper JW, “Percutaneous Absorption of Salicylic Acid in Rabbits,” Academy of Pharmaceutical Sciences, May 16, 1977, New York, New York, Proceedings.

* 10. Cooper JW, “Real World Drug Problems of the Elderly Patient,”Invitational Paper to Workshop on Pharmacology and Aging, National Institutes of Health and Aging, September 15, 1977, Proceedings.

* 11. Cooper JW, “Iatrogenic/Self Induced Hyperkalemia in an Elderly Female,” to Academy of Pharmacy Practice, May 17, 1978, Montreal, Canada,Proceedings.

* 12. Cooper JW, “Consultant Pharmacist Effect on Drug Usage in the Long Term Care Facility,” American Society of Consultant Pharmacists Annual Meeting, November 2, 1978, Atlanta, Georgia, Proceedings.

* 13. Williamson DH, Cooper JW, Kotzan JA, “Consultant Pharmacist Effect on Antihypertensive Therapy in the Long Term Care Facility,” American Society of Hospital Pharmacists Mid Year Clinical Meeting, December 5, 1978, San Antonio, Texas, Proceedings.

* 14. Cooper JW, “Drug Regimen Review in the Elderly Patient,” American Society of Consultant Pharmacists, November 16, 1979, Dallas, Texas, Proceedings.

* 15. Wilcher DE, Cooper JW, “Consultant Pharmacist Effect on Analgesic Antiinflammatory Usage in Geriatric Long Term Care Facility,” ASHP Mid Year Clinical Meeting, December 3 4, 1979, Las Vegas, Nevada,Proceedings.

* 16. Tsai A, Cooper JW, McCall CY, “Consultant Pharmacist Effect on Hematopoietic and Vitamin Therapy in a Geriatric Long Term Care Facility,” ASHP Mid Year Clinical Meeting, December 3 4, 1979, Las Vegas, Nevada, Proceedings.

* 17. Lawler RS, Cooper JW, Kotzan JA, “Consultant Pharmacist Input to Treatment of Urinary Tract Infections in a Geriatric Long Term Care Facility,” presented to ASHP Mid Year Clinical Meeting, December 3 4, 1979, Las Vegas, Nevada, Proceedings.

* 18. Cooper JW, Francisco GE, “Consultant Clinical Pharmacist Effect on Psychotropic Usage in Long Term Care Facility Geriatric Patients,” ASHP Mid Year Clinical Meeting, December 3 4, 1979, Las Vegas, Nevada, Proceedings.

** 19. Marcantonio SM, Cooper JW, McCall CY, Mandell GL,”Dexamethasone Prevention of Cisplatinum Nausea and Emesis,” 12th Annual Southeastern Regional Conference on Hospital Pharmacy, March 7, 1981.

** 20. Wilcox JT, Francis WR, Francisco GE, Cooper JW, “Drug Information in U.S.Army Hospitals,” ibid.

** 21. Griffin DL, Francis WR, Francisco GE, Cooper JW, “Pharmacist Contribution to Home Health Care,” ibid.

** 22. Pink LA, Cooper JW, Francis WR, McCall CY, “Pharmacist Input to Digoxin Usage and Effect in a Geriatric Long Term Care Facility,” ibid.

* 23. Spruill WJ, Cooper JW, Taylor WS, “Pharmacist Coordinated Pneumonia and Influenza Vaccination Program,” ASHP Mid Year Clinical Meeting, December, 1981, New Orleans, Louisana, Proceedings.
* 24. Griffin DL, Francisco GE, Cooper JW, Francis WR,”The Pharmacist in Home Health Care,” ibid.

* 25. Wade WE, Cobb HH, Cooper JW, “Drug Related Problems in a Geriatric Ambulatory Population”, ASHP Midyear Clinical Meeting, December 1983, Atlanta, Proceedings.

* 26. Cooper JW, McCall CY, Longe RL, Braucher CL,”The Use of Slow Scan Television for Small Group Therapeutics Lectures.” Am J Pharm Ed. 48:80, 1984.

** 27. Durrence CE, May JR, DiPiro JT, Cooper JW. Drug Interactions in Surgical Patients, 15th Annual Southeastern Conference for Hospital Pharmacy, Athens, Georgia, March 1982.

* 28. Cooper JW, “Drug Related Problems in a Geriatric Long Term Care Facility,” 18th Annual ASCP Meeting, Orlando, 1984.

* 29. Cooper JW, Cobb HH, Shepherd MD, “Drug Discards in Two Georgia LTCFs,” ASHP Mid year Clinical meeting, Dallas, Dec.1984.

** 30. Miller MJ, Cooper JW, Erwin WG, “Efficacy of a Transdermal Patch Product in Geriatric Long Term Care Patients with Angina”, Sixteenth Annual Southeastern Conference for Post Graduate Pharmacy Education and Training, (SECPGPET) 1985.

** 31. Morton MR, Cooper JW, Spruill WJ, Fincham JE, “Pnuemococcal Vaccine Efficacy in a Geriatric LTCF Population, ibid. March 1986.

* 32. Cooper JW, “Transdermal Nitroglycerin Efficacy in Ambulatory Geriatric Patients”. ASHP Mid year, New Orleans, December 1985.

* 33. Cooper JW, “Nursing Home Admission Orders and The Consultant Pharmacist” ASCP Meeting, New Orleans, November, 1986.

* 34. Doyal LE, Cooper JW, “Cost Justification of the Clinical Pharmacist in a Community Mental Health Center”, ASHP Mid Year Meeting, Las Vegas, December, 1986.

** 35. Mallet L, Cooper JW, Wade WE. “Anemia Detection, Prevalence and Treatment Outcome in a Geriatric LTCF Population”. Abstract of 17th SECPGPET meeting, March 1987.

* 36. Cooper JW. “Constipation in the Elderly Patient”. ASCP Mid year meeting, San Diego, May, 1987.

* 37. Cooper JW and Department faculty, “Pharmacy Practice Research”, 1980 1987,” to American Association of Colleges of Pharmacy (AACP), Charleston, July 1987.

** 38. Cooper JW, “How to Deal with the Nursing Home Patient” to region III AACP/NABP Meeting, Biloxi, August, 1987.

*** 39. Cooper JW,” The Development of Consultant Pharmacy in the United States of America”, to Second International Conference on Professional Orientation, Valencia, Spain, November 1987.

*** 40. Cooper JW, ” Geriatrics Pharmacy Practice Contribution to Nursing Home Care in The United States of America” to Second International Congress on Geriatric Pharmacotherapy and Nutrition, Alicante Spain, November 1987.

* 41. Morton MR, Cooper JW,” Digoxin Erythromycin Interaction” to ASHP Mid year Clinical Meeting, Atlanta, December 1987.

* 42. Mallet L, Cooper JW, ” Anemia Development Prediction to ibid.

** 43. Cooper JW, “Geriatric Pharmacy Research at the University of Georgia and Medical College of Georgia”, to University System Advances in Geriatrics and Gerontology, Athens, March, 1988.

** 44. Cooper JW, “Drug Related Problems in the Elderly”, to ibid.

* 45. Cooper JW, Consultant Pharmacist Impact in Health Care: Past, Present and Future, to the American Pharmaceutical Association, Atlanta, March, 1988.

* 46. Mallet L, Cooper JW, “Effect of Intensive Pharmacist Rounding on Nursing Home Care”, ASHP Mid Year Clinical Meeting, Dallas TX, December, 1988.

*** 47. Cooper JW, “The Physician and Pharmacist Roles in Geriatric Patient Compliance”, Hawaiian Medical, Pharmacists and Hospital Pharmacists Societies, Honolulu, September 1989.

*** 48. Cooper JW, “Geriatric Pharmacy Education in the USA”, 3rd International Congress on Geriatric Pharmacotherapy, Alicante, Spain, October 1989.

* 49. Morton MR, Spruill WJ, Cooper JW, Fincham JE, Respiratory infections in Nursing Home Patients Receiving Pnuemococcal and Influenza Vaccines, American Geriatrics Society, May, 1990.

* 50. Cooper JW, Jordan TL, Psychotropics and Falls in Nursing Home Patients. ibid.

* 51. Cooper JW, “Psychoactive Drug Effects in a 200 Geriatric Nursing Home Population” to Pharmacy Science Liaisons of The Upjohn Company, February 1990.

** 52. Jordan TL, Cooper JW, “Adverse Events of Psychotropic Drugs in a Geriatric Nursing Home Population” to Southeastern Postgraduate Education Conference, Athens, April 1990 and American Society of Consultant Pharmacists, San Antonio, November, 1990.

** 53. Gordon JE, Cooper JW, “Diabetes Treatment and Complication Outcomes in a Geriatric Nursing Home A Three Year Study”, to ibid.

** 54. Cooper AE, Cooper JW, “Diuretic Usage and Electrolyte Effects in a Geriatric Nursing Home,” ibid.

*** 55. Cooper JW, “The Development of the Doctor of Pharmacy Degree in The United States of America” to Korean Society of Hospital Pharmacists, Seoul, October 1990.

*** 56. Cooper JW, “Consultant Pharmacists Effect on Diabetes Mellitus Treatment Outcomes in Two Nursing Facilities”, American Society Consultant Pharmacists Annual Meeting , Montreal, November, 1991; Georgia Society of Hospital Pharmacists, Atlanta, 1992

* 57. ” Drug Related Costs and The Elderly” to the Senate Special Committee on Aging, Invited Expert Witness Testimony at the request of Senators David Pryor and Wyche Fowler, Atlanta, April 1992.

*** 58. Cooper JW, “Using ‘Prove it’ to Document the Value of Your Clinical Services”, ASCP, Montreal, Canada, November, 1992

*** 59. Cooper JW, “Geriatric Pharmacotherapy Issues in the United States of America”, Fourth International Congress on Geriatric Pharmacotherapy and Nutrition, Valencia, Spain. 1992

*** 60. Cooper JW, Bristol Royal Health Care Trust Department of Pharmacy, “Clinical Pharmacy Services in Acute and Long Term Care”, Bristol, UK, 25 Aug 1992

*** 61. Cooper JW, Bristol and Weston UK Health Care Districts, “Pharmacy Care in the Community: Experience from the USA”, 27 Aug 92

*** 62. Cooper JW, The School of Pharmacy, University of London,”Impact of the Consultant Pharmacist on Health Care”, 2 Sep 92

*** 63. Cooper JW, Royal Pharmaceutical Society of Great Britain, Scottish Headquarters, Edinburgh, Lothian Pharmacy Practice Group, “Consultant Pharmacist Contributions to Health Care in the United States of America”,3 Sep 92.

*** 64. Cooper JW, British Pharmaceutical Conference, Geriatric Pharmacy Association Meeting, Birmingham, ” Remarks on Consultant Pharmacist Activities at All Levels of Care”, 9 Sep 92

* 65. Cooper JW,” Pharmacotherapy of Depression in Nursing Home Patients-15 years of Pharmacoepdemiologic Results”, Am. Soc. of Cons.Pharmacicts, Orlando, November, 1992.

* 66. Cooper JW, “Pharmacotherapy Recommendations from Monthly Drug Regimen Reviews in a Geriatric Nursing Facility: A One-Year Study” to American College of Clinical Pharmacy Meeting, San Diego, CA February, 1994

*** 67. Cooper JW,” Consultant Pharmacy in the United States of America” to the 3rd International Congress On Unit_Dose Distribution Systems, Alicante, Spain, June 1994.

*** 68. Cooper JW, “Drug Concerns in the the Elderly Patient” to ibid.

*** 69. Cooper JW,”Pharmaceutical Care in the United States of America: Practical Outcome Measures” to Universities of Valencia, Alicante, Cordoba, Granada and Seville and Jaen Pharmacists Society, Spain, June 1994.

* 70. Cooper JW, “Consultant Pharmacist Effect on NSAID Gastropathy over a 5-year Period” to ASCP Meeting, November, 1995

* 71. Cooper JW, “COPD Case Study” to ibid.

* 72. Cooper JW, “Oral Antiviral Safety in the Treatment of Herpes Zoster”, ibid.

** 73. McRae A, Cooper JW. “Nonaggressive short-term nutritional supplementation in a nursing home population” to Southeastern Post-graduate Conference. Athens, GA, May 1996.

*** 74. Cooper JW. Fall risk assessment and reduction within the nursing facility, ASCP meeting abstract p.406-7,, Nashville, November 1996.

*** 75. Cooper JW. Psychoactive-associated fall injury assessment, costs and reduction within the nursing facility, ibid., abstract #23.

*** 76. Cooper JW, Chapman N. Fall risk assessment within the hospital setting, ibid., November 1996.

*** 77. Cooper JW. Approaches for reducing psychotropic-related fall injuries in long term care: treatment of anxiety and agitation, ibid.

*** 78. Cooper JW. Pharmaceutical care and the role of the pharmacist in arthritis therapy, ibid.

*** 79. Cooper JW. Reducing psychotropic-related falls and injuries, agitation, aggression and anxiety in geriatric patients, to American Medical Directors Association, Phoenix, February, 1997.

*** 80. Cooper JW. Buspirone conversion effect on reducing psychoactive-associated falls and fall-related injuries and dementia-associated agitation and aggression in long-term care patients to American Geriatrics Society and American Federation for Aging Research 1997 Annual Scientific Meeting, Atlanta, May, 1997.

***81. Cooper JW. A Pharmacoeconomic analysis of buspirone conversion effect on fall and drug costs and agitation management, to the National Association of Directors of Nursing Administration/Long Term Care, Austin, June 1997.

**82. Janampally R, Cooper JW, et al. Evaluation of the treatment of depression and dementia in a geriatric nursing facility, to 28th Southeastern Residency Conference, Athens, May, 1997.
**83. Cooper JW. Diabetes Treatment Outcomes. Tennessee Society of Consultant Pharmacists, Nashville, August, 1997.

**84. Cooper JW. Depression Treatment Outcomes. Tennessee Society of Consultant Pharmacists, Nashville, August, 1997.

**85. Cooper JW. Falls and Agitation Treatment Outcomes. Tennessee Society of Consultant Pharmacists, Nashville, August, 1997.

**86. Cooper JW. Psychoactive medication related falls. Ohio Medical Association, Columbus, August, 1997.

*87. Cooper JW. Reduction of Falls, Injuries and Agitation in the Nursing Home, National Conference of Geriatric Nurse Practitioners, San Francisco, September, 1997.

*** 88. Cooper JW. Fall Risk Assessment and Reduction within The Nursing Facility, World Congress of Gerontology, Adelaide, August, 1997 Accepted, unable to present.

* 89. Cooper JW, Wade WE. Pharmacist interventions regarding NSAID therapy in a geriatric nursing facility. American College of Clinical Pharmacy, Cincinnati, November 1998, Pharmacotherapy 1998;18:1771.and 1999 University System of Georgia Research Symposium, Augusta, March 1999.

*90. Cooper JW. Osteporosis interventions in a nursing facility: calcium intake assessment and supplementation over a one-year period. American Society of Consultant Pharmacists, Seattle, November 1998.

**91. Cooper JW. Secondary Stroke Prevention Interventions in a Nursing facility Population: A One-year Study, 1999 University System of Georgia Research Symposium, Augusta, March 1999.

**92. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Calcium Intake Assessment to ibid.

**93. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Dietary Calcium Supplementation Trial to ibid.

**94. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Pharmacologic Calcium Supplementation Results to ibid.

**95. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Hormone Replacement Results to ibid.
**96. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Alendronate Outcomes to ibid.

**97. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Calcitonin Nasal Spray Outcomes to ibid.

***98. Cooper JW. Reducing geriatric adverse drug reactions in nursing facility patients to American Societies of Health-System Pharmacists (December) and Consultant Pharmacists (November), 1999.

***99. Cooper JW. Drug-associated appetite and weight changes in long-term care residents: a 5-year study, Long-Term Care Visiting Faculty Program, St. Petersburg, November, 1999.

**100. Cooper JW. Prevention of geriatric adverse drug reactions. Grand Rounds via Videoconference to University of Texas Health Center-affiliated hospitals, January, 2000.

**101. Cooper JW. Advances in Fluoroquinolone Therapy to South Carolina Advanced Nurse Practice Institute, Charleston SC, February, 2000

**102. Horner MR, Cooper JW. Psychotropics, Fall and Hospitalization Risk to Southeastern Postgraduate Conference, Athens, April, 2000.

*** 103. Cooper JW. Pharmacoeconomics of Geriatric Pain, to ASCP Meeting, Las Vegas, May, 2000.

*** 104. Cooper JW. Secondary Stroke Prevention in a Nursing Faciliy Population:A One-Year Study to the American Geriatrics Society/.American Federation for Aging Research Meeting, Nashville, May 2000

*** 105. Cooper JW. Special Drug Considerations in the Geriatric Patient, Lamda Kappa Sigma National Meeting, Houston, August 2000 (4 hours)

**106. Cooper JW. Safe medication use for the older adult (3 hours) to Northeast Georgia Medical Senior Wellness Seminar, Gainesville, June, 2000.

** 107. Cooper JW. Avelox in URTIs, Atlanta, March, 2000.

*108. Cooper JW. Hypolipdemic therapy, Columbus, February, 2000.

*** 109. Cooper JW. Pinnacle Award Acceptance Speech, Canadian Embassy, Washington, DC, June, 2000.
** 110. Cooper JW. Appropriate analgesic treatment in the older adult., GPhA meeting, Amelia Island, Florida, June, 2000.

**111. Cooper JW. Improving medication use in seniors. Savannah area professional groups, July, 2000.

** 112. Cooper JW. Geriatric Research Update. American Medical Directors Association, Georgia Chapter meeting, Callaway Gardens, July, 2000.

** 113. Cooper JW. Optimal Pain management for the geriatric patient. Miss. Soc. Cons. Pharm., Jackson, October, 2000.

***114. Cooper JW. Interactive case management of pain in the senior care patient. American Society of Consultant Pharmacists (ASCP), Boston, November, 2000 (videotape and slides to be online at ASCP.com)

***115. Cooper JW. New advances in treatment of type 2 diabetes mellitus. Ibid. speaker and panel moderator.

***116. Cooper JW. Treatment of depression in geriatric nursing facility residents. Ibid. speaker and session moderator.

***117. Cooper JW. NSAID interventions in senior care recipients to ASCP, November, 2000.

*** 118. Cooper JW. Are beta blockers more poorly tolerated in the elderly patient? Invited presentation to industry advisory panel at the American Heart Association meeting, New Orleans, November 2000.

***119. Cooper JW, Horner MR. Psychotropic load, falls and hospitalization. Amer. Soc.
Health Sys Pharm Mid-year clinical meeting, Las Vegas, December, 2000, abstract 511E

*** 120. Cooper JW. NSAID and platelet-affecting interventions in geriatric patients to ibid.

*** 121. Cooper JW. Drug treatment issues in patients with dementia. Invited participant to Joint Conference on Legal and Ethical Issues in the Progression of Dementia, UGa Law School, December, 2000.

** 122. Cooper JW. Reducing Psychotropic-related falls in nursing facility residents. Georgia geriatrics Society, Atlanta, January 2001 and Ga. ASCP Chapter, February, 2001.

**123. Cooper JW. Drug-related Problems in Older Adults-Consulting ooportunities for Pharmacists, to Michigan Pharmacists Association, Dearborn, MI, February, 2001

*** 124. Cooper JW. Psychotropic Issues in Geriatric Patients, to National Psychiatric Practitioners Conference, Athens, GA, February, 2001

*** 125. Cooper JW. Psychotropic Polypharmacy Case Management to ibid.

** 126. Cooper JW. Pain management for the older adult. Florida Pharmacists Association, Destin, February, 2001.

***127. Cooper JW. Safe Medication Use in the Older Adult. American Pharmaceutical Association, San Francisco, March, 2001

***128. Cooper JW. Drug-related Problems in an Ambulatory Adult Day Care and Senior Citizen Center Population, ibid.

***129. Cooper JW, Wade WE. Pharmacist intervention in geriatric NSAID usage: Outcomes, to Drug Information Association, Savannah, March 2001

** 130. Cooper JW. Adverse drug reactions in a medicaid population. Georgia medical Care Foundation, Atlanta, March, 2001.

** 131. Cooper JW. Liver function tests and assessment in a geriatric population. Wisconsin Society of Pharmacists , April, 2001.

** 132. Cooper JW. Medication assessment and use in dementia. Alzhiemers Assocation of Georgia, Atlanta, February, 2001.

**133. Cooper JW. Encouraging safe medication use in assisted living residents. Huntcliffe Summit, Atlanta, April, 2001.

*** 134. Cooper JW. Pain management in the cognitively impaired adult. American Society of Consultant Pharmacists, Washington, DC, May 2001.

**135. Cooper JW. Behavioral management and psychotropic drugs in dementia. Kentucky Long-Term Care Nurses Association, Louisville, KY, May 2001.

**136. Cooper JW. Fall and osteoporosis risk intervention. Pharmerica conference, Hendersonville, KY, June, 2001.

**137. Cooper JW. Fall prevention in the elderly. Kentucky Pharmacists Association, Lexington, and Ga. ASCP chapter, Atlanta, June, 2001.

*** 138. Cooper JW. Pain management issues in the older adult. Joint Commission on Accreditation of Health Care Organizations Pain Summit, Phoenix, AZ, June, 2001.

***139. Cooper JW. Assessment and treatment of non-malignant pain in the older adult. Grand Rounds, Howard University School of Medicine, Washington, DC, May, 2001.

** 140. Cooper JW. Fall and injury prevention in nursing facility residents. SC ASCP chapter, Columbia, July, 2001. And Auburn CE Programs, August, 2001.

**141. Cooper JW. Safe medication use for the older adult. Colorado Pharmacists Assoc. August and Iowa Pharmacists, September, 2001.

***142. Cooper JW. Perioperative pain management outcomes. American College of Surgeons, New Orleans, October, 2001.

***143. Cooper JW. Development of safe medication use systems for adults. National Community Pharmacists Association, Philadelphia, October, 2001.

***144. Cooper JW. Osteoporosis, falls and injury interventions. Mississippi Society of Consultant Pharmacists, Jackson, October, 2001.

***145. Cooper JW. Pain management in palliative care. ASCP, Chicago, November, 2001.

***146. Cooper JW. Advanced concepts in geriatric problem solving. ASCP, Chicago, November, 2001.

**147. Cooper JW. Infectious disease overview. Mercer University School of Medicine, family practice dept. Grand Rounds, Macon, September, 2001.

***148. Cooper JW. Psychotropic management issues in the geriatric patient. American Society of Health-System Pharmacists, New Orleans, December, 2001.

***149. Cooper JW. Drug-related problems in older adults- consulting opportunities for pharmacists to ibid.

***150. Cooper JW. Cardiovascular implications and COX-2s to Managed Health Care Associates at ASHP meeting, New Orleans, December, 2001.

** 151. Cooper JW. Safe Medication Use in the Older Adult. Sunrise Assisted Living Caregivers, Atlanta, 7 Jan 02.

**152. Cooper JW. Preventing Medication Errors in Long Term Care. Sunscript LTC Meeting, Atlanta, 15 Jan 02.

**153. Cooper JW. Improving drug use in assisted living residents. Legacy link, Gainesville, Ga 7 Feb 02.

**154. Cooper JW. Advanced concepts in geriatric drug therapy problem-solving. Georgia AMDA meeting, Marietta, GA 16 Feb 02.

155. Cooper JW. Pain Management in Cognitively Intact and Impaired Older Adults. Macon Pharmacists Association, 28 Feb 02.

***156. Cooper JW. Development of Medication Management Systems for Assisted Living and Nursing Facility Patients, American Pharmaceutical Association, Philadelphia, 18 Mar 02.

***157. Cooper JW. Drug-related problems in older adults. ibid, 18 Mar 02.

**158. Cooper JW. Special drug considerations in older adults (4.5hrs) to Michigan Pharmacists Association, 22 Feb 02.

**159. Cooper JW. Advanced concepts in older adults pharmacotherapy problem-solving (6 hrs). Pharmacy Society of Wisconsin, 9 Apr 02.

**160. Cooper JW. Falls and incontinence to Pharmerica Nursing home nurses, Macon, 22 Apr 02.

**161. Cooper JW. Osteoporosis Interventions by the pharmacist. Tennessess Pharmacists Association, Knoxville, 14 May, 19 and 26 June 02.

**162. Cooper JW. Fluoroquinolones in respiratory and urinary tract infections. Grady Hospital Pharmacy Clinical Staff, Atlanta, 23 May 02.

*163. Cooper JW. Therapeutic advances in COX-2 selective therapy, Georgia Pharmacists Association, Panama City, 8 June 02.

*164. Cooper JW. Safe medication use in the older adult project, Georgia Pharmacists Association, Panama City, 8 June 02 and 7 Ga. Citiies over June-Sep 2002.

* 165. Cooper JW. Safe medication use in the older adult, Georgia Department of Human Resources, Division of Aging Services, 13 June 2002.

166. *Cooper JW. ADR Intervention in nursing facility patients. Georgia AMDA, ASCP and NADONA Chapters, Reynolds Plantation, GA 12 June 2002.

167. **Cooper JW. Dementia- Delirium-Depression Assessment and Treatment in Nursing Home Patients- Outcomes. Auburn Geriatrics Symposia, Gulf Shores, AL and Lake Guntersville, AL, Julu and August 2002.

168. **Cooper JW. Falls and Urinary Incontinence. Maryland ASCP Chapter, Rocky Gap, 10 Aug 2002.

169. **Cooper JW. Advanced Problem Solving in Geriatric Patients. Mississippi Society of Consultant Pharmacists (6 hrs.). Jackson, 27 Sep 02.

170.*** Cooper JW. Cultural and cognitive differences in pain management. ASCP, Anaheim, 13 Nov 02.

171. * Cooper JW. Infectious disease treatment in geriatric patients. Samford University Geriatrics symposium.(3 hrs) 17 Nov 02.

172. Cooper JW. Practical Pain Management for older adults. Eldercare pharmacists, Augusta, 6 Dec 02.

173. Cooper JW. Practical Pain interventions in elderly patients. ASHP Mid-year Clinical meeting, Atlanta, 11 Dec 02.

NOTE-averaged 70-120 similar local to regional presentations/year 2003-7.

*National;**Regional; ***International Presentation; Otherwise, Local to State Presentation Other invited Lectures and Seminars (past available on request)-over 1200 presented to pharmacy, nursing, physician, gerontology, consumer, industry as well as interdisciplinary groups in 46 of 50 states and 7 countries outside USA over past 30 years.

Web CE

Snader T, Cooper JW. Undertreatment of geriatric pain. www.ascp.com, 2000

Cooper JW. EENT Infections, TB, UTIs and Bone and Joint Infections to Non-traditional Pharm.D. Program, Mercer University SouthernSchool of Pharmacy and UGa, 2001-2006

Cooper JW, Beier M, Cranmer K. Palliative Care and End of Life Issues in Long Term Care Facilities, www.ascp.co, 2001

Cooper JW, Beier M, Assessment and Appropriate Treatment of Geriatric Pain: A Call to Action, www.ascp.com, 2000.

Cooper, JW. Consultant Pharmacy and Long Term Care- see book 28 above.

Cooper JW. Geriatric Drug Therapy- A Guidebook for Pharmacists to prepare for Medicare Part D Counseling and Interventions, see book 29 above.

Electronic Media

Videotapes-1. Training Senior Center Workers to Assist the Elderly with their Medications. Georgia Center 1980 (four one-half hour tapes) to be used with “Drugs and the Older Adult”- please see book no.2 above.

2. Assessing Medications in the Elderly Patient. Medical University of South Carolina, 1987, 16 hours.

3. Recognition and Management of Depression (see 10. books and monographs above) 0.5 hours

4. Drug-Related Problems at All levels of Care. Mercer University Southern School of Pharmacy, 1995, 0.5 hours.

Audiotapes-

1. Cooper JW, Cobb HH. Clinical outcomes in pharmacy research. Medical Outlook, The Cortlandt Group, Ossining, NY, 1994.

2-10. Presentations at ASCP and NARD Meetings on Lab Tests and Case Studies, and antiinfectives, and Falls 1992, 1993,1994, 1995, 1996, 1997, 1998, 2000 and 2001

11. The First Peter P. Lamy Memorial Lecture, ASCP, November, 1999.

CD-ROM

1. Grossberg GT, Cooper JW. Managing agitation and preventing falls in the elderly. Medical Communications Media, Inc. Langhorne, PA, 1997.

2. Cooper JW. Treatment of RTIs and UTIs with Fluroroquinolones. Pharmerica via Bayer Grant, 2002. Used in teleconference to 400+ LTCFs.

Book and Educational Reviews

(all J.W. Cooper sole author, except where indicated)

1. A Manual of Adverse Drug Interactions. Am J Pharm Ed 1976; 40:323 324.

2. Handbook of Drug Treatment. Am J Pharm Ed 1977; 41:249.

3. Drug Induced Nutrition Deficiencies. Am J Pharm Ed 1977; 41:545.

4. Medication Guide for Patient Counseling, Am J Pharm Ed 1978; 42:241 242.

5.Cooper JW, Francisco GE. Drugs and the Aged. Am J Hosp Pharm 1981;38:131 2.

6. Drug Treatment in the Elderly. J Geriatr Drug Ther 1986; 1: 83.

7. Handbook of Nutrition in the Aged.ibid. 1987;1(4):97 98.

8. Geriatric Pharmacology and Therapeutics. J Geriatr Drug Ther 1987;1(4):101 103.

9. Handbook of Nutrition in the Aged. J Geriatr Drug Ther 1988; 2(4):90 91.

10. Drugs and The Elderly.Geriatr Med Today 1990;3 5.

11. Therapeutics in the Elderly. J Geriatr Drug Ther 1988; 3(2):103 4.

12. Cooper JW, Longe RL. Introduction to Physical Assessment and Clinical Laboratory
Medicine. Am J Pharm Ed 1979; 43:324.

13. Cooper JW, Jordan TL. Worst Pills Best Pills. J Geriatr Drug Ther 1990;4(4):111 112.

14. Pharmacoepidemiology:An Introduction. J Pharmacoepi 1990; 1(2):65 66.

15. Clinical Pharmacology in the Elderly. J Geriatr Drug Ther 1990; 5(1):83 84.

16. USPDI Vol. I and II. J Geriatr Drug Ther 1991;6(1):85 86.

17. About Your Medicines, 6th ed. J Geriatr Drug Ther 1991; 6(2): 87 88.

18. Handbook of Drug Therapy in Liver and Kidney Disease. J Geriatr Drug Ther 1992;7(1): 92-93.

19. Handbook of Prescribing Medications for Geriatric Patients. J Geriatr Drug Ther 1993;7(3):67.

20. USPDI Vol. I and II. ibid. 1993;7(4):85-86.

21. Drug Prescribing for the Elderly. ibid. 1993; 8(2): 61-62.

22. Geriatric Dosage Handbook.J Geriatr Drug Ther 1993;8(1):89-90.

23. Pharmacotherapy: A Pathophysiologic Approach, 2nd. ed. ibid. 1994;8(3): 95-96.

24. USPDI Vol.I and II. ibid. 1994;8(4):83-84.

25. Exploring Geriatric Therapeutics Vol.1, programs 1-3. J Geriatr Drug Ther 1994;9(2):77.

26. Practical Handbook of Psychopharmacology. ibid. 1995;9(4):67-8.

27. Home Health Care Practice. ibid. 1995;9(3):85-6.

28. Antimicrobial therapy in the elderly, ibid. 1995;10(1):79-80.

29. Therapeutics in the elderly, 2nd ed., ibid. 1996;10(2):73-74.

30. AGS complete guide to aging and health, ibid.1996;10(4):71-72.

31. Merck manual of geriatrics, 2nd ed., ibid. 1996;11(1):71.

32. Cooper JW. Therapeutics in the elderly, 3rd ed., Am J Health-Syst Pharm 2001; 58, 1459.

Book Chapters

(BC-x) (NOTE: separate chapters those * are in books listed below)

1. Cooper JW, “Problems in the Real World The Patient,” NIH Workshop on Pharmacology and Aging Proceedings, September 15 16,1977, Bethesda,Maryland, DHEQ Pub. No. (NIH) 78 353.

2. Cooper JW, “Drug Related Problems and the Elderly,” chapter in Eldercare: A Guide to Clinical Geriatrics, by M. O’Hara Devereaux and L. H. Andrus.New York: Grune and Stratton, 1980.

3. Cooper JW, “Monitoring Drug Therapy in an Extended Care Facility,” book chapter in Problems in Geriatric Drug Therapy. Menlo Park, CA.Addison Wesley Pub. Co., 1981.

4. Cooper JW, “Consultant Pharmacy,” in Smith and Brown (Ed) Handbook of Institutional Pharmacy Practice, Williams and Wilkins, Baltimore, 1985.

5. Cooper JW, “Antihistamines and Decongestants in The Treatment of Chronic Rhinitis”, New England and Regional Allergy Proceedings Vol. 1,1984.

6. Cooper JW, “H 1 Blockers, Classical Antihistamines” in “H1 and H2 Histamine Receptors” G.Settipane editor, Ocean Side Pub., Inc. Providence, RI 1988.

7. Cooper JW, “Pharmacy Service to Long Term Care Patients” in T.R. Brown Handbook of Institutional Practice, ASHP 1992.

8. Cooper “Classical Antihistamines and Decongestants in the Treatment of Chronic Rhinitis”in Rhinitis, G. Settipane, ed., 2nd. ed., 1991.

9. *Cooper JW, Geriatric drug therapy interventions@ in, Cooper JW. (ed./co-au.)
Geriatric drug therapy interventions, Pharmaceutical Products Press, 1997.

10. *Cooper JW, Wade WE. AConstipation in the Geriatric Patient@, in Gastrointestinal Drug Therapy in the Elderly. Pharmaceutical Products Press, Binghamton, NY, 1997.

11. *Cooper JW, Wade WE. ADiarrhea in the Geriatric Patient@.in Gastrointestinal Drug Therapy in the Elderly. Pharmaceutical Products Press, Binghamton, NY, 1997.

12. *Wade WE, Cooper JW. Gastroesophageal reflux disease in the elderly@,in Gastrointestinal Drug Therapy in the Elderly. Pharmaceutical Products Press, Binghamton, NY, 1997.

13. *Wade WE, Cooper JW. AInflammatory bowel disease in the elderly patient@,in Gastrointestinal Drug Therapy in the Elderly. Pharmaceutical Products Press, Binghamton, NY, 1997.

14. *Wade WE, Cooper JW. AManaging hyperuricemia and gout in the geriatric patient@ in Chisholm MA, Cooper JW (eds.), Musculoskeletal drug therapy for geriatric patients. Pharmaceutical Products Press, Binghamton, NY, 1999.

15. * Cooper JW, Groce J. Antithrombotic therapy in the long-term care setting: reassessing the risk of deep venous thrombosis and pulmonary embolism in the acutely ill medical patient, in Cooper JW, Groce J, Advances in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Supplement D to The Consultant Pharmacist 2001; vol. 16. ASCP, Alexandria VA, 2001

16. *Cooper JW, Groce J . DVT/PE Prophylaxis in medically ill patients: a new avenue of clinical management in the long-term care setting, in Cooper JW, Groce J, Advances in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Supplement D to The Consultant Pharmacist 2001; vol. 16. , ASCP, Alexandria VA, 2001

17. *Groce J, Cooper JW. The pharmacoeconomics of low-molecular weight heparins: getting the most bang for the health care buck, in Cooper JW, Groce J, Advances in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Supplement D to The Consultant Pharmacist 2001; vol. 16., ASCP, Alexandria VA, 2001.

18. Cooper JW. Adverse drug reactions, medication errors and chemical restraints, chapter in Braun JL and Capezutti L (eds), Litigating Injuries in the Elderly: A Legal medical Reference Guide to Nursing Homes and Assisted Living Facilities, 2002.

19. Cooper JW. The Role of Expert Witnesses:Pharmacists, part of chapter in Braun JL and Capezutti L ibid.

Books, Monographs and Manuals (B-x) all JW Cooper author, unless otherwise noted

1. Cooper JW, Gerson CK, Smith CA. Conducting an Inservice Training Program, American Pharmaceutical Association, Washington, D.C., 1981

2. “Drugs and the Older Adult”, Georgia Center for Continuing Education, Athens,1982, 2nd ed. 1989.

3. “Process Guide to Clinical Orientation”, UGA Press, 1980.

4. “Community and Nursing Home Drug Monitoring Guidelines 1990″ , Consultant Press, Watkinsville, GA.; 1993 edition

5. ” Drug Related Problems in Geriatric Nursing Home Patients”, Haworth Press, New York, NY, 1991.

6. McCombs J, Cooper JW. “Externship Manual”College of Pharmacy UGA, (5th ed.), 1989 Ed. 2 4 1976 85.

7. Perri M, Cooper JW,”Alzheimer’s Counseling Guidebook for Pharmacists “, Medical Publishing Enterprises, 1994.

8. Cooper JW, Ouslander JG, Small RE, Oles KS, (eds.) “Benign Prostatic Hyperplasia: Treatment Advances”, American Pharmaceutical Association, Washington DC, 1992.

9. Cooper JW, Piepho RW, “Cost-effective Management of Benign Prostatic Hyperplasia”, SCP Communications, New York, NY 1994.

10. Cooper JW, Gordon N, Radovich C, Siegal AP. “The Recognition and Management of Depression in the Long-term Care Institution”, NCM Publishers, Inc. New York, NY 1995.(and videotape)

11. Cooper JW, Davis S, Miller C. “Management of Lower respiratory Tract Infections in the Elderly Long-Term Care Facility Resident”. Health Sciences Institute, Philadelphia, 1995.

12. Cooper JW. (ed.) “Antiinfectives in the Elderly”. Pharmaceutical Products Press, Binghamton, NY, 1995.

13. Cooper JW. (ed.) “Antivirals in the Elderly”. Pharmaceutical Products Press, Binghamton, NY, 1996.

14. Cooper JW. (ed./author) “Urinary Incontinence in the Elderly: Pharmacotherapy Treatment.” Pharmaceutical Products Press, Binghamton, NY, 1997.

15. Cooper JW. (co-author and ed.). “Geriatric Drug Therapy Interventions”. Pharmaceutical Products Press, Binghamton, NY, 1997.

16. Cooper JW, Wade WE. (co-authors and co-eds.) “Gastrointestinal Drug Therapy in the Elderly.” Pharmaceutical Products Press, Binghamton, NY, 1997.

17. Carvalho MG, Cooper JW, Fossen MS. Lieberman JA, Wise MG. Rational therapy: persistent anxiety. ICPRx, Boston, MA, 1997.

18. Cooper JW, Kurlowicz LH, White P. Management of depression in elderly residents of long-term care facilities. Medical Education Systems, Inc., Philadelphia, PA, 1997.

19. Cooper JW, Hooker RS. Minimizing NSAID-related GI toxicity. Supplement to Drug Topics, 17 Feb 1998.

20. Cooper JW, Hughes AC. Headache Assessment and Treatment, Consultant Press, Watkinsville GA1999.

21. Cooper JW, Hughes AC. Polypharmacy Management in the Older Adult, ibid. 1999.

22. Cooper JW (editor and co-author) Diabetes mellitus in the elderly, Haworth Press, 1999.

23. Chisholm M, Cooper JW. Musculoskeletal disease drug therapy for geriatric patients, Haworth Press, Binghamton, NY, 1999.

24. Armstrong EP, Cooper JW. (Eds.) Atypical antispychotics: administrative issues and cost differentiation, Medical Education Systems, Philadelphia, 1999.

25. Bykowski KJ, Cooper JW, Narayan P, Stello B. Rational therapy: Pharmacologic management of benign prostatic hyperplasia, Institute for Integrated Healthcare, Wellesley, MA 1999

26. File TM, Cantrell HF, Cooper JW. Antiinfective therapy guide-2000. Antibiotic puzzle, Inc. Greenville, SC, 2000., 2001 and 2002 editions

27. Cooper JW, Groce J, Advances in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Supplement D to The Consultant Pharmacist 2001; vol. 16. (see chapters in previous section), ASCP, Alexandria VA, 2001

28. Cooper JW. Consultant Pharmacy and Long Term Care Patient Certification Program: An Introduction and Clinical Tools for the beginning Consultant Pharmacist. Consultant Press, 1200 Colliers Creek Rd. Watkinsville, GA 30677-1867. Available solely through www.shca-ga.org and www.rxugace.com. Til October 2008.

29. Cooper JW, Burfield AH. Geriatric Medication Therapy Management Certificate Program:Drug Therapy Guide- a practical guide and clinical tools for the pharmacist. ibid.

30. Cooper JW, Burfield AH. Laboratory tests and Physical Assessment for Drug Therapy. Ibid. pending release 2008

Professional Articles page two

151. Urinary Incontinence: An Underrecognized Problem, Nursing Homes, 1991; 40(4):46 48.

152. Diabetes Mellitus Management in the Nursing Home. Nursing Homes and Senior Citizen Care (NHSCC)1992; 41(1): 34 35.

153. Pain Management in Long Term Care. NHSCC 1992; 41(2): 26 28.

154. *Managing Antihypertensive Therapy in Long Term Care. Clin Cons 1992; 11(1): 1 8.

155. *Drug related Problems in Geriatric Nursing Home Patients. Pharm Times 1992; 58(8):60 69.

156-7.* Drug-level Monitoring: Parts 1 and 2. LTC Pharmacist.1992;1(11). 3-5 and 1993; 2(1):2-3.

158. Managing Disruptive Behavioral Symptoms: Do’s and Don’t’s.Nursing Homes 1993;42(1):35-37 and 1994;43(1):54-56.

159.* Effects of Dementia: Differentiating Dementing Illness and Related Problems. Amer Drug 1993; 29(Apr):59-68.

160. Drugs That Cause Falls in the Nursing Home. Nursing Homes 1993; 42(4):45-47.

161.* Clinical Outcomes Research in Pharmacy Practice. Amer Phar 1993;NS33(12):S7- S13.

162. Functioning in the “Real World” of Nursing Home Pharmacotherapy. NH Practitioner 1993;1(1):43-44.

163. *Peripheral Vascular Disease Basic Bibliography. Hosp Pharm 1994; 29(1):81-82.

164. *Management of Angina Pectoris. Clin Consult 1993; 12(8): 1-8.

165. *Management of Laboratory Tests I: Serum Chemistry, Renal Function and Urinalysis. Clin Consult 1994; 13 (1):1-7.

166. *Management of Laboratory Tests II: Hematology and Clotting. Clin Consult 1994; 13(2): 1-8.

167. *Stewart RB, Cooper JW .Polypharmacy and Aging. Drugs and Aging 1994;4(6):449-461.

168. *Drug Therapy Problems in the Elderly. Generations 1994;18(2):19-27.

169. *Geriatric Pharmacotherapy Issues in the United States of America. J Geriatr Drug Ther 1996;11(4): 1-28.

170. Scheduled Drug in the Nursing Home. NH Practitioner, 1994;2(1):41-43.

171. *NSAIDs: Proceed with Caution.NH Practitioner 1994; 2(2):32-33.

172. Dementia,Depression and Drugs.Nurs Homes 1994; 43(2): 44-45.

173. Tuberculosis I: Assessing Risk and need for Treatment. Regimen 1994;3(4):1-5.

174. Tuberculosis II. Drug Treatment. Regimen 1994;3(5): 1-6.

175. *Medication Errors in the Elderly. Fl J Hosp Pharm 1994; 14(1):23-25.

176. Improving Professional Collaboration in Today’s Nursing Home. Nurs Homes 1994; 43(5):32-38.

177. Keeping Scheduled Drugs Secure in the Nursing Home. Nurs Homes 1994:43(6):24-25.

178. New Drug Developments. Nurs Home Pract 1994;2(3):33.35.

179. Pharmacotherapy:The OBRA Team-Physicians and Pharmacists
Upgrading Therapy. ibid.2(4):31-34.

180. NSAIDs and the Elderly Patient. Regimen 1994;3(6):1-5.

181. Assessing the Need for Enteral Feedings.Regimen 1994;3(7):1-5.
182. Managing Acute and Chronic Pain. Regimen 1994;3(8):1-5.

183. Flu and the Elderly Patient. Regimen 1994;3(9):1-5.

184. Seizures and Related Medications in the Nursing Home Patient. Regimen 1994;3(10):105.

185. Managing Diabetes Mellitus in the Nursing Home Resident. Regimen 1994;3(11):1-5.

186. Stroke Management in the Nursing Home Resident. Regimen 1994;3(12):1-5.

187.* A Primer on Drug Level Monitoring of Nursing Facility Residents. Brown U LTC Quality Letter 1993;5(13):1-3.

188. *Careful Drug-Level Monitoring Reduces Drug Toxicity. ibid.5(14):1,6.

189-201. Editorials. J Geriatr Drug Ther 1991-1995; volumes 6-9 (1-4 each).

202. A Farewell. J Geriatr Drug Ther 1994;9(2):1.

203. Preventing Falls and Fractures. NH Pract 1994;2(6):28-30.

204. Anxiolytic Update NH Pract 1995;3(1):19-21.

205. Monitoring Pulmonary Therapy. Regimen 1995;4(1):1-4.

206. Preventing Falls and Fractures in Nursing Home Patients. Regimen 1995;4(2):1-4.

207. Monitoring Psychoactive Drug Use in Nursing Home Patients. Regimen 1995;4(3):1-4.

208. NSAIDs:Gastrointestinal Effects. Long Term Care Pharmacist 1994;3(7):3.

209. GI Disease Overview. GPhA Academy of Independent Pharmacists Newsletter 1995 (4 parts).

210. Antidepressant Need and Assessment and Usage. NH Pract 1995; 3(2):19-21.

211. Antidiabetic Usage in Long Term Care. NH Pract 1995; 3(3):27-30.

212. ACE Inhibitors and the Nursing Home Patient. Regimen 1995;4(4):1-4.

213. Understanding and Managing Sleep Disorders in the Nursing Home Patient. Regimen 1995;4(5):1-4.

214. Monitoring Parkinsonism Drug Therapy. Regimen 1995;4(6):1-4.

215. Antianginal Drug Therapy Management. Regimen 1995;4(7):1-4.

216. Assesing High Blood Pressure. Regimen 1995;4(8):1-4.

217. High Blood Pressure Medications: Diuretics & ACE Inhibitors. Regimen 1995;4(9):1-4.

218. Influenza and the Nursing Home Resident. Regimen 1995;4(10):1-4.

219. Blood Pressure Management in the Edlerly. Regimen 1995;4(11):1-4.

220. Use of Drug Levels I: Digoxin. NH Pract 1995;3(4):20-22.

221. Use of Drug Levels II: Theophylline and Anticonvulsants. NH Pract 1995;3(5):19-21.

222. Helicobacter pylori in Nursing Home Residents. NH Pract 1995;3(6):17-19.

223. Monitoring upper respiratory tract infections in the nursing facility resident. Regimen 1995; 3(12):1-4.

224. Monitoring lower respiratory tract infections in the nursing facility resident. Regimen 1996; 4(1):1-4.

225. Managing pneumonia in the nursing home. Regimen 1996; 4(2):1-4.

226. Managing acute UTIs in the nursing facility. Regimen 1996; 4(3): 1-4.

227. Managing chronic UTIs in the nursing facility patient. Regimen 1996; 4(4):1-4.

228. Skin Problems in the nursing facility:skin changes and atopic dermatitis. Regimen 1996;4(5):1-4.

229. Contact dermatitis, infections and infestations in the nursing facility. Regimen 1996; 4(6):1-4.

230. Prevention of pressure ulcers. Regimen 1996;4(7):1-4.

231. Treatment of pressure ulcers. Regimen 1996;4(8):1-4.

232. Precose for diabetes mellitus. Regimen 1996;4(9):1-4.

233. Glucophage for diabetes mellitus. Regimen 1996;4(10):1-4.

234. Fall risk assessment and reduction. Regimen 1996;4(11):1-4.

235. Osteporosis risk assessment and treatment. Regimen 1996;4(12):1-4.

236.* Cooper JW, Wade WE. Constipation in the Geriatric Patient, J Geriatr Drug Ther 1997:12(1): 49-70..

237.* Cooper JW, Wade WE. Diarrhea in the Geriatric Patient ibid.: 71-92.

238. * Wade WE, Cooper JW. Gastroesophageal reflux disease in the elderly, ibid.:3-14.

239.* Wade WE, Cooper JW. Inflammatory bowel disease in the elderly patient, ibid.:33-48.

240.* Antiinfective therapy in the geriatric patient. Infusion 1997;3(6):10-19.

241. Lung problems in the nursing home patient: acute and chronic cough, Regimen 1997;5(1):1-5.

242. COPD management considerations in the nursing facility. Regimen 1997;5(2):1-4.

243. Gastrointestinal problems in the nursing facility resident: nausea, vomiting, flatulence and lactase deficiency, Regimen 1997;5(3):1-5.

244. Hiatal hernia and gastroesophageal reflux disease in nursing facility residents. Regimen 1997;5(4):1-4.

245. Gastritis and peptic ulcer disease in nursing facility residents. Regimen 1997;5(5):1-4.

246. Monitoring constipation and diarrhea in nursing facility residents. Regimen 1997;5(6): 1-4.

247.*Stroke prevention and post-stroke rehabilitation bibliography. J Geriatr Drug Ther 1996;11(2):45-57.

248. * Treatment of Urinary incontinence in the elderly: a bibliography. J Geriatr Drug Ther 1997; 11(3): 61-72.

249. Assessing Cognition and Depression in Nursing Home and Long-term Care Patients. Regimen 1997; 5(7): 1-4.

250. Minimization of Psychoactive Drugs in Nursing Home Patients. Regimen 1997; 5(8): 1-4.

251. Assessing arthritic pain in the frail and elderly nursing home resident. Regimen 1997: 5(9):1-4.

252. Treating arthritic pain with analgesics and non-acetyl salicylates. Regimen 1997; 5(10):1-4.

253. Treating the arthritic patient with NSAIDs. Regimen 1997;5(11):1-4.

254. Arthritic patient pain management.: narcotic analgesics and antidepressants. Regimen 1997; 5(12): 1-4.

255. Dementia-associated agitation, aggression and disruptive behavior in nursing facility residents. Regimen 1998; 6(1):1-4.

256. Non-pharmacologic treatment of agitation, aggression and disruptive
behavior. Regimen 1998; 6(2): 1-4.

257. Pharmacologic treatment of dementia-associated agitation and aggression. Regimen 1998; 6(3): 1-4.

256. Beta blocker use in nursing facility patients. Regimen 1998; 6(4): 1-4.

257. The use of calcium channel blockers in nursing facility residents. Regimen 1998;6(5):1-4.

258. Hypolipidemic therapy in nursing facility patients. Regimen 1998; 6(6): 1-4.

259. Constipation in the geriatric nursing facility patient. Regimen 1998; 6(7): 1-4.

260. Causes and treatment of diarrhea in the geriatric nursing facility patient. Regimen 1998; 6(8):1-4.

261. Evaluating polypharmacy among nursing facility residents. Regimen 1998; 6(9): 1-4.

262. Polypharmacy-related problems among nursing facility residents. Regimen 1998; 6(10): 1-4.

263. Unnecessary and inappropriate drugs in the nursing facility resident. Regimen 1998; 6(11);1-5.

264. Reducing adverse drug reactions and hospitalizations among nursing facility residents. Regimen 1998; 6(12):1-4.

265. Parkinsonism-related drug therapy in nursing home patients. Regimen 1999; 7(1)@ 1-4.

266. Causes and treatments of urinary incontinence in nursing facility patients. Regimen 1999; 7(2):1-4.

267. Diabetes mellitus in nursing facility patients: new guidelines for assessment and treatment overview. Regimen 1999; 7(3):1-4.

268. Newer oral hypoglycemics for the diabetic nursing facility resident: acarbose and miglitol. Regimen 1999; 7(4):1-4.

269. Oral agent therapy of type 2 diabetes mellitus in nursing facility residents: metformin, troglitazone, sulfonylureas and repaglinide. Regimen 1999; 7(5/6): 1-4.

270. Osteoporosis assessment, prevention and treatment within the nursing facility. Regimen 1999; 7(7/8):1-4. Via Internet site ncpa.org

271. Osteoporosis Treatment. Regimen 1999; 7(9/10):1-4 Via internet site ncpa.org

272. Congestive heart failure in nursing facility residents. Regimen 1999; 7(11/12), via ncpa.org

273.* Nonpharmacologic and pharmcologic treatment of dementia-associated agitation, aggression and disruptive behaviors. J Geratr Drug Ther 1999; 12(3):5-28.

274. Congestive heart failure II. Regimen 2000; 8(1/2): 1-4.

275. *Adverse Drug Reactions in Geriatric Nursing Facility Residents. Medscape 2000; 18 Jan issue via medscape.com

276. Fluoroquinolone usage in nursing facility residents. Regimen 2000; 8(3/4):1-4.

277. Arthritic patient pain management in nursing facility residents: assessment. Regimen 2000; 8(5/6):1-4.

278. Arthritic patient pain management in nursing facility residents:Treatment with peripheral analgesics. Regimen 2000; 8(7/8):1-4.

279. Arthritic patient pain management in nursing facility residents: Treatment with non-steroidal antiinflammatory drugs (NSAIDs). Regimen 2000; 8(9/10):1-4

280.Arthritic patient pain management in nursing facility residents: Moderate to severe pain management-narcotic analgesics and adjunctive agents. Regimen 2000; 8(11/12):1-4.

281. *Arginine monograph . The Natural Pharmacist. (tnp.com) 2000.

280. *Multiple Sclerosis. America=s Pharmacist 2000; 122(7): 61-67.

281. Preventing falls by pharmacist medication management. Regimen 2001;9(1/2):1-4.

282. *Preventing falls through medication management by the pharmacist. Ga Pharm Quart 2001; 78(1):2,4,7,12, 15.

283. Laboratory assessment of geriatric drug therapy: rationale, regulations and frequency. Regimen 2001;9(3/4):1-4.

286. Cooper JW. Fluid and electrolytes assessment in geriatric patients-Fluids. Regimen 2001;9(5/6):1-4.

287.*Cooper JW. Safe medication use in the older adult. J APhA 2001; 41(suppl1): S46-47.

288.Cooper JW. Prevention of adverse drug reactions in older adults. America=s Pharmacist. 2001:123(12):53-60.

289. Cooper JW. Serum electrolyte assessment in geriatric patients. Regimen 2001; 9(7/8):1-4.

290. Cooper JW. Blood gases and acid-base balance in geriatric patients. Regimen 2001;9(9/10):1-4.

291. Cooper JW. Renal function assessment and urinalysis in geriatric patients. Regimen 2001; 9(11/12):1-4.

292. Cooper JW. Oral drug therapy for type 2 diabetes mellitus in the elderly. Clinical Consult 2001: (4):1-8.

293. Cooper JW. Serum and urine glucose in geriatric patients. Regimen 2002; 10(1 /2);1-4.

294. Cooper JW. Hematology and hemostasis. Regimen 2002; 10 (3/4):1-4.

295. Cooper JW. Red blood cell formation and hemostasis. Regimen 2002; 10(5/6):1-4.

296. Cooper JW. Drug Levels- A Practical Guide for The Senior Care Pharmacist. Regimen 2002;10(7/8):1-4.

297. Cooper JW. Hepatic Function and Disease Indices in Nursing Home Patients. Regimen 2002;10(9/10):1-4.

298. Cooper JW. Liver Functional Reserve, Drug-Induced Damage and Drug Dosing in Liver Impairment. Regimen 2002; 10 (11/12):1-4.

299-300. Cooper JW. Inappropriate drug use in the elderly: revised Beer’s Criteria for 2003.Regimen 2003; 11(1/2):1-4. And (3/4):1-4.

301. Cooper JW. Burfield AH. Medication Therapy Management (MTM) Strategies for Geriatric Patient Interventions: Medicare Part D Implementation. Ann Long Term Care 2007; 15(7):33-38.

Professional Articles (page one)

(JWC single author unless otherwise noted) ( P-x)
Refereed=*
1. The emphasis is on clinical pharmacy. Pharm Quart 1974;6:5 8.

2. *Hexachloraphene vs. povidone iodine in the control and prophylaxis of neonatal and surgical infection. Hosp Form Mgt 1974; 9:12 14.

3.* Cooper JW, Campbell NA. Community hospital practitioner consultation: is the patient profile a viable means of future role expansion and professional unification. J Amer Pharm Assoc 1975; NS15 484 488.

4.* Fish KH, Cooper JW. The development of a non computerized system for drug drug interaction detection. J Amer Pharm Assoc 1975;NSl5:1,28 31. And 2000; 40:545.

5. The Common Cold and Cold Remedies, syndicated to 200 New England Newspapers via University of Rhode Island Public Information Office, January 1975.

6. Upper and Downers, syndicated to 200 New England Newspapers via University of Rhode Island Public Information Office, February, 1975.

7.* Fish KH, Cooper JW, Schwartz PA. Teaching process skills in clinical pharmacy orientation. Am J Pharm Ed 1975;40:306 309.

8.* Implications of Drug Reactions Recognition, Incidence and Prevention, RI Med J 1975; 59:274 288.

9. Patient Profiles Why Bother?.Pharm Quart 1975; 7: 3 7.

10. Community and Hospital Pharmacist How They Cooperate to Reduce Medication Problems. Pharm Times 1975;41; 40 44.

11. Pharmacists Work Together to Improve Patient Care.Trends in Pharmacy (July August, 1975).

12.* Food Drug Interactions. US Pharm 1976; 1:17 28.

13.* Drug Related Problems and the Elderly. Sou Pharm J 1977; 69:11 15.

14.* Urinary Tract Infections I.Cause and Prevention. Hosp Form 1977;12:106 110.

15.* Urinary Tract Infections II.Optimal Therapy. Hosp Form 1977; 12:175 183.

16.* Creatinine Clearance Projection. Hosp Form 1977; 12:283.

17.* Chronic Obstructive Airway Disorders I. Asthma. Hosp Form 1977; 12:524 529.

18.* Chronic Obstructive Airway Disorders II. Chronic Bronchitis and Emphysema Hosp Form 1977;12:579 582.

19.* Cooper JW, et al.Patient Medication Profiles. Pharm J of Great Britain 1977; 52 71.

20. *Nalidixic Acid. Hosp Form 1977; 12:634 6 (Letter).

21.* Drug Therapy in the Elderly Is It All It Could Be? Amer Pharm 1978;NS18:25 26.

22.* Prophylaxis with Steroids in Asthma. Hosp Form 1978;13:654 656 (Letters).

23. Drug Related Problems and Patient Education.Ga Pharm Quart 1978; 55:1.

24.* Cooper JW, et. al. Pharmacy and the Elderly, U.S. DHWE HRA Pub. No. 232 78 0176 (February 15, 1979).

25.* The Role of Clinical Pharmacy in Pharmacy Practice.Ga Pharm 1979; 32:8 9.

26. Standards for Consultant Pharmacy. Contemp Adm 1979; 2:18 19.

27. Drug Use Review in LTCF. Pharm Pract editorial, 1979; 12:30.

28. Drug Distribution Systems in LTCF. Contemp Adm 1979; 2:21 22.

29. Clinical Functions of the Consultant Pharmacist,ibid.(7), 1979; 19 20, 30.

30. Literature of Consultant Pharmacy, ibid.(8):26 7.

31. Medication Errors in the LTCF Definition, Recognition and Prevention,ibid.(10), 27 28.

32. Drug History Acquisition, Interview, Evaluation and Communication, ibid.,3:18 19 (January, 1980).

33.* Diuretics in the Elderly Patient. Drug Ther 1979; 9:l0 (Letter).

34. Committee Functions of the Consultant Pharmacist. Contemp Adm 1980;3(2):17 18.

35. Drug Related Problems and the Geriatric Patient. Drug Store News 1980;3(4):8 16.

36. Writing A Problem List for the LTCF Patient, Contemp Adm 1981; 3(4):6 8.

37. Stop Order Policy for the LTC Facility. Contemp Adm 1980; 3(5):12.

38. Policy and Procedure Manual Development, ibid., 1981; 4(1):9.

39. Professional Publications. Ga Pharm Quart 1980; 57, (4):2.

40. Drug Regimen Review in the LTC Facility. Contemp Adm 1980; 3(7):98.

41. Formulary System in Long Term Care Facilities,ibid., 1981; 4(3):11.

42. Consultant Pharmacy Roles and Resources. Drug Store News 1981;3:2.

43. Books for Continued Clinical Education. Ga Pharm Quart 1981;58 No. 1, 2.

44. Practitioner Oriented Periodicals. Ga Pharm J 1981; 4:1.

45. Pharmacist Clinical Functions I-Drug History.Drug Store News 1981;3

46. Vitamin K Deficiency and Replacement. Ga Pharm Quart 1981 58, (2):2.

47.* Assessing Antihypertensive Therapy in the Geriatric Patient. Clinical Cons 1981; l(4).

48. Adverse Drug Reactions and Interactions in the Long Term Care Patient. Contemp Adm 1981;4(9):30, 36.

49. Medication Regimen Compliance in the LTC Patient ibid. 1981; 4(10):20.

50. High Blood Pressure in the Elderly.ibid. 1981; 4(11):8,25..

51. Diuretic Antihypertensives in the LTC Patient.ibid.1981; 4(10):20.

52. Potassium Supplementation in the LTC Patient.ibid. 1981; 4(12):40 41.

53. Sympatholytic Antihypertensives.ibid.1982;(1):30 31

54. Vasodilator Antihypertensives. ibid.1982; 5(2):18.

55. The Drug Cutbacks. Contemp Adm 1982; 5(3):32 33

56. Staff Education and Drug Use Control. Contemp Adm 1982; 5(5):8 10.

57. Nitroglycerin Oral Dosage Forms.ibid. 1982; 5(6):10 12.

58. Nitroglycerin Topical Dosage Forms. ibid. 1982; 5(7):7.

59. Beta Blocking Agents. ibid. 1982; 5(9):14.

60. The Problem List. Contemp Adm 1982; 5(12):26 28.

61. Consulting Pharmacist.ibid. 1983; 6(1):24.

62. Using the New Indicators.ibid. 1983; 6(2):4 6.

63. Drug Therapy Situations Requiring Communications.ibid. 1983; 6(3):18.

64. Drug Irregularities Documentation. ibid. 1983; 6(4): 4, 30.

65. Monitoring Drug Interactions in the Geriatric LTC Patient. Clin Consult,1983; 3: No. 2.

66. Use Digitalis with Care. Contemp Adm 1982; 5(11):34.

67. *Reactions to Post Graduate Education. Drug Intel Clin Pharm 1984; 18:330.

68. *Allopurinol Warfarin Interaction. Drug Ther 1984; 14:155. (letter)

69. Detection and Treatment of Sexually Transmitted Diseases. Drug Store News 1985.

70. Nutrient and Drug Interrelationships ibid. 4 Apr 1985.

71. Digoxin Drug Interactions. Contemp Adm 1984; 7(2):20 22.

72. Diuretic Drug Interactions. ibid. 1984; 7(3):36 38.

73. Anticonvulsant Interactions ibid. 1984;7(4):19 23.

74. Consultant Pharmacist Qualifications and Functions. Nurs Homes 1984;33(2):12 13.

75. The Need for Consultant Pharmacist Services in Long Term Care ibid.33(6):11 12.

76. Medication Errors in Nursing Homes Part I ibid. 1985;34(1):12 13.

77. Medication Errors in Nursing Homes Part II ibid. 1985(2);34:12 14.

78.* Sublingual Nitroglycerin at the Bedside. J Am Med Assoc 1984; 252:1926.

79. Antihypertensive Drug Interactions: Part I. Nurs Homes 1985; 34(3):11 12.

80. ibid. Parts II & III. 11 13.

81. Anticoagulant Drug Interactions. Part I. ibid.34(4):17 19.

82. ibid. Part II. 15 17.

83. Neuroactive Drug Interactions in the LTCF Patient: Part I- Assumptions and Questions. Nurs Homes 35:12 15 1986.

84. ibid. Part II 16 20.

85. Digitalis Drug Interactions. ibid. 1986;35 35 39.

86. Gastrointestinal Drug Interactions. ibid. 48 51.

87. Antidiabetes Drug Interactions. Ibid., 63 68.

88.* Wade WE, Cooper JW. Monitoring Therapy in the HypertensivePatient-I. US Pharm 1985; 10(6):46 53.

89. *Wade WE, Cooper JW. Monitoring the Hypertensive Patient II. Patient Information. ibid.(7):46 50.

90. Monitoring Anticonvulsant Drug Interactions and Blood Levels. Nursing Homes 1986; 35(6):11 13.

91. Monitoring Pulmonary Therapy ibid. 35(6):21 24.

92.* H 1 Blockers: Classical Antihistamines. New Engl Reg Allerg Proc 1987; 7:356 361.

93 103. Editorials. J Geriatr Drug Ther 1986-1988; 1(1):1. 2:(4):1

104.* Drug Related Problems at all levels of Geriatric Patient Care. J Geriatr Drug Ther 1990; 4(3):79 83.

105.* Drug Related Problems in Nursing Home Patients. Generat 1988; 12(4):56 7.

106.* Cost Savings: The Value of the Pharmacist Consultant. J Pharm Pract 1988;1:173 7.

107.* Consultant Pharmacist Impact on Health Care in America. Cons Pharm 1988; 3:342 6.

108 116. Editorials. J Geriatr Drug Ther 1988 90 Vol. 3 No. 1 thru Vol. 4 No.4.

117. Current Geriatric Drug Therapy Literature Citations. J Geriatr Drug Ther 1987; 2(1):79 87.

118. Current Geriatric Pharmacokinetic Literature Citations ibid., 3(1):93 9.

119. Current Geriatric Cardiovascular Literature Citations. ibid. (2):105 113.

120. Current NSAID Literature ibid. (4):151 2.

121. Current Adverse Drug Reactions ibid. (3):107 9.

122. Current Immunotherapy, Psychotropic and Renal Function Literature ibid.4(3).77 79.

123. Physician and Pharmacist Roles in Patient Compliance. Pharm Times 1990;25:9 71.

124.* The Development of Geriatric Education in the United States of America,3rd International Congress on Geriatric Pharmacotherapy Proceedings, Alicante, Spain October 1989 Geriatrica 1989;5(9):22 28, Pharmalink 1990; 3(6):9 21. and J Geriatr Drug Ther 1991; 5(4):21 38.

125. Mammy Blue. J Geriatr Drug Ther 1990; 4(3); 3 5.

126. Problems in Dealing With the Nursing Home Patient, ibid. 1990; 4(1):51 58.

127. *Special Drug Considerations in the Last Year of Life. Geriatr 1989;44(12):79 86.

128. Gramps. J Geriatr Drug Ther 1990; 4(4):5 6.

129.* Drug Abuse in Nursing Homes, used by Rep. Mario Biaggi as reference in Hearing before Select Committee on Aging, House of Representatives, 96th Congress, June 25, 1978.

130.* Management of Diabetes Mellitus Complications, Clinical Consult 1990; 9(3):1 6.131. Diabetes in the Elderly. J Geriatr Drug Ther 1990; 5(1):1 2.

132. Diabetes Citations. ibid. 85 87.

133. OBRA Regulations and Chemical Restraints. Nurs Homes 1990; 39(6):10 13.

134. Chemical Substance Impaired Health Care Professional ibid. (5); 6 7, 36.

135. Use of Chemical Restraints in Nursing Homes ibid.1989; 38 (1&2):5 7.

136. High Blood Pressure Monitoring Guidelines: Diuretics. ibid. (3):7 9.

137. Congestive Heart Failure Management Guidelines.ibid. 1990; 39(1):8 10.

138. High Blood Pressure Monitoring Guidelines: Sympatholytics and Vasodilators ibid. (2):7 9.

139 142. Editorials J Geriatr Drug Ther 1990 1991; 5(1 4).

143. *Geriatric Pharmacy Education in the United States of American ibid.; 5(4):26 38.

144. Renal Geriatric Citations, ibid. 5(3):91 3.

145.*Stroke Management. Clin Consult 1991;10(2):1 6.

146. *Peripheral Vascular Disease ibid. (3):1 6.

147. *Liver Assessment in Long Term Care Patients. ibid.(4):1 6.

148. What to Expect from your Consultant Pharmacist. Nurs Homes 1991; 40(1):37 39.

149. Pressure Sores in the Nursing Facility,ibid.(2):39 41.

150. Infection Control in Nursing Homes,ibid.(3):42 44.

Publications

Research (R-x) *=refereed
1. *Cooper JW. Serotonin and growth antagonists. New Engl J Med 1973; 289:870 (Letter).

2. *Cooper JW, Ansel HC, Cadwallader DE. Liquid and solid solution interactions of primary certified colorants with pharmaceutical gelatins. J Pharm Sci 1973;62:1156 1164.

3. *Cooper JW, Fish KH, Loomis M et al., A seven nursing home study of the frequency of potential drug drug interactions. J Am Pharm Assoc 1975; NS23:24 27.

4. *Cooper JW, Frisk PA, Walchle RC. Continuous clinical pharmacy care-a method to reduce drug related problems in the small community. J Clin Pharmacol 1975; 15: 55.

5. *Cooper JW, Rhodes CT, Birmingham BK. Pharmacokinetics of salicylic acid. Arch Derm 1976; 112:1610 (Letter).

6. *Lewis KP, Cooper JW, McKercher PL. Pharmacist effect on digoxin usage and toxicity. Amer J Hosp Pharm 1976;33:1272 1276. NOTE: Dr. Lewis was first recipient of the ASHP Student Research Award in 1978 for this work.

7. *Frisk PA, Cooper JW, Campbell NA. Community hospital pharmacist detection of drug related problems upon admission to small community hospitals. Am J Hosp Pharm 1977;34:738 742. Note: This work received the ASHP Award for Achievement in the Professional Practice of Hospital Pharmacy in 1978.

8. *Schwartz PA, Rhodes CT, Cooper JW. Solubility and ionization characteristics of phenytoin. J Pharm Sci 1977;66:994 997.

9. *Cooper JW, Bagwell CG . The contribution of the consultant pharmacist to rational drug usage in the long term care facility. J Am Geriatr Soc 1978;26:513 520.

10. *Cooper JW, Pesnell LS. Thioridazine associated immune hemolytic anemia in an elderly female. Sou Med J 1978;71:1441 1442.

11. *Cooper JW, Walchle RC, McKercher PL. Physician, pharmacist and nurse conducted drug histories. Contemp Pharm Pract 1980;3:75 78.

12. *Cooper JW, McCall CY. Tetracycline esophagitis report of three cases. Pharm Practice. 1979;14:52.

13. *Cooper JW, McCall CY. Tolmetin anaphylactoid reaction. JAMA 1980;243:1263.

14. *Cooper JW. Consultant contributions to rational drug therapy in the long term care facility. Contemp Writings on Long Term Care Pharmacy 1980;2:161 168.

15. *Wade WE, Whaley JA, Cooper JW, Brown RH . Pharmacist involvement in Georgia public health department preliminary report of two pilot studies. Ga Pharm J 1981;3:20 22.

16. *Wilcher DE, Cooper JW. Consultant pharmacist effect on analgesic and antiinflammatory usage in geriatric long term care facility. J Am Geriatr Soc 1981;29:429 432. NOTE: Ms. Wilcher was Sigma Xi Student Research Awardee for this work in 1982.

17. *Tsai AE, Cooper JW, McCall CY. Consultant pharmacist effect on hematopoietic and vitamin therapy in a geriatric long term care facility. Hosp Form 1982;17:225 235.

18. * Lawler RS, Cooper JW, Kotzan JA. Consultant pharmacist input in the treatment of urinary tract infections in a geriatric long term care facility. Hosp Pharm 1980;15:562 572.

19. *Cooper JW, Francisco GE. Consultant clinical pharmacist: effect on psychotropic drug usage in long term care facility geriatric patients. Hosp Form 1981;16:407 419.

20. *Williamson DH, Cooper JW, Kotzan JA. Consultant pharmacist impact on antihypertensive therapy in a geriatric long term care facility. Hosp Form 1984;19:123 128.

21. *Cooper JW. Baked chicken liver and blood pressure increases in geriatric nursing home patients. Am J Clin Nutr 1979;32:1980.

22. * Cooper JW et al., Pharmacy and the Elderly: An Assessment of the Needs of the Elderly and Recommendations for Increasing Geriatric Aspects of Pharmacy Curricula, DHEW Pub. No.(HRA) 80 37 (September, 1979).

23. *Cooper JW, Griffin DL, Francisco GE, et al. Home health care: drug-related problems detected by consultant pharmacist participation. Hosp Form 1985;20:643 650.

24. * Wiederholt J, Kotzan JA, Cooper JW. A tachistoscopic examination of auxiliary prescription labels. Drug Intell Clin Pharm 1983; 17:216 221.

25. *Spruill WJ, Cooper JW, Taylor WJR. Pharmacist coordinated pneumonia and influenza vaccination program. Am J Hosp Pharm 1982; 39:1904 1906.

26. * Spruill WJ, Cooper JW. Enteric coated aspirin efficacy in patients previously treated with non steroidal antiinflammatory agents. Sou Med J 1983; 76:276.

27. *Cooper JW. Drug related problems in geriatric LTCF patients. J Geriatr Drug Ther 1986; 1(1):47 68.

28. * Cooper JW. Effect of initiation, termination and reinitiation of consultant pharmacist services in a geriatric LTCF. Med Care 1985;23:84 86.

29. *Cooper JW, Morgan SM, McCall CY, et al. Dexamethasone prevention of cisplatinum induced nausea and emesis. Curr Ther Res 1985; 38:43 49.

30. * Cooper JW, Cobb HH, Shepherd MD. Drug discards in two Georgia long-term care facilities. Ga Pharm J 1985; 7:11 15.

31. * Cooper JW, Stegeman JF. Sulfisoxazole induced hypoprothrombinemia in an elderly female. J Med Assoc Ga 1981; 70:875 877.

32. * Pink LA, Cooper JW, Francis WR. Digoxin related communications in a long term care facility. Nurs Homes 1985; 34(1):25 31.

33. * Durrence CE, Cooper JW. Gastrointestinal side effects associated with liquid and solid dosage forms of potassium chloride. Curr Ther Res 1984;36:550 556.

34. *Cooper JW. Efficacy and cost effectiveness of a new diuretic combination antihypertensive in a geriatrics long term care facility. Curr Ther Res 1986; 39:160 165.

35. * Wade WE, Cobb HH, Cooper JW. Drug-related problems in a geriatric ambulatory population. J Geriatr Drug Ther 1986; 1(2):101 110.

36. * Durrence CE, May JR, DiPiro JT, Cooper JW. Potential drug interactions in surgical patients. Am J Hosp Pharm 1985; 42:1553 1556.

37. Cooper JW. Trans dermal nitroglycerin efficacy in ambulatory and nursing home geriatric patients. MCP CE Bulletin 1986; 6:25 32.

38. Cooper JW. Drug related problems in nursing home patients. Nurs Homes 1986;35(6): 13 19.

39. Cooper JW. Communications on drug related problems within nursing homes. Nurs Homes 1987; 36(1):11 14.

40. Cooper JW. Drug related problems in nursing homes: Medication Errors.Nurs Homes1987; 36(2):13 16.

41. Cooper JW. Drug related problems in nursing home patients: contraindications to drug usage. Nurs Homes 1987;36(3):5 7.

42. Cooper JW. Adverse drug reactions and interactions in a nursing home. Nurs Homes 1987; 36(4):7 11.

43. Cooper JW. Nutritional problems in nursing home patients. Nurs Homes 1987; 36(5):5 8.

44. Cooper JW . Nursing home drug and nutritional therapy cost savings by the consultant pharmacist. Nurs Homes 1987; 36(6):6 8.

45. Cooper JW. Reduction of irrational drug duplication in geriatric nursing homes. Nurs Homes 1988; 37(1):5 9.

46. Cooper JW. Lack of efficacy of nursing home medications. Nurs Homes 1988;37:(2)6 10.

47. Cooper JW. Underecognition and undertreatment of geriatric nursing home patients. Nurs Homes 1988;37(3):6,9. and *Ga J Hosp Pharm 1989;2(2):18-20.

48. Cooper JW. Lab tests under and overutilization in geriatric nursing home patients. Nurs Homes 1988;37(4):5 8.

49. Cooper JW . Inappropriate drug scheduling. Nurs Homes 1988; 37(5):13 15.

50. * Cooper JW, Cobb HH. Patient nutritional correlates and changes in a geriatric nursing home. Nutr Supp Serv 1988; 8(8):5 7.

51. *Wade WE, Cooper JW. Iatrogenic hyperkalemia in a elderly female. J Geriatr Drug Ther 1986; 1(1):75 79.

52. * Cooper JW, Wade WE, Mallet L. Anemia detection and treatment in a four geriatric long term care facility population. J Pharmacoepidem 1990; 1(1):61 70.

53. *Cooper JW. Nursing home admission orders and the consultant pharmacist. Cons Pharm 1987; 2:152 156.

54. * Cooper JW, Doyal LE. Cost justification of the clinical pharmacist in a community mental health center. Med Interface 1989; 2(11):44 48.

55. * Cooper JW. Drug related problems in geriatric day care patients. Cons Pharm 1988;3(2):193.

56. * Cooper JW. Reduced eye infections in geriatric patients by consultant pharmacist recommendation of continual use of artificial tears. Cons Pharm 1988;3(3):83.

57. * Cooper JW. Drug related problems (DRPs) in geriatric swing bed patients.Cons Pharm 1988;3 (3):83.

58. * Cooper JW. Cost savings from discontinuance of urinary sugar and acetone tests. Cons Pharm 1988;3(3):83.

59. * Morton MR, Spruill WJ, Cooper JW. Pharmacist impact on pneumococcal vaccination rates in LTCFs. Am J Hosp Pharm 1988; 45:73.

60. * Cooper JW. Chronic constipation associations and laxative efficacy in a geriatric nursing home population. J Pharmacoepidem 1991;1(3/4):29 40.

61. * Mallet L, Cooper JW. Catapres TTS medication error. Sou Med J 1988; 81:1597 1598.

62. * Cooper JW, Mallet L. Chlorpropamide half life and urine pH. Am J Med 1988; 85:756 757.

63. * Mallet L, Cooper JW, Thomas J. Captopril pemphigoid reaction. Drug Intell Clin Pharm.1989; 23:63.

64. * Fazio A, Lisi DM, Cooper JW. Acetazolamide Acidosis. J Geriatr Drug Ther 1989;3(3):87 96.

65. * Mallet L, Coulter J, Cooper JW. Cholesterol levels in elderly patients living in a nursing home .Cons Pharm 1989;4:371 373.

66. * Morton MR, Cooper JW. Erythromycin induced digoxin toxicity. DICP Ann Pharmacother 1989; 23:688 9.

67. Cooper JW. Psychoactive drug use and misuse in a 200 bed nursing home population. Nurs Homes 1989;38(1 2):5 7.

68. * Cooper JW, Gordon JE, Parish RC. Diabetes mellitus prevalence and treatment outcomes in a geriatric nursing home population. J Geriatr Drug Ther. 1990; 5(1):73 82.

69. * Cooper JW. Renal function assessment in nursing home patients. A prospective 6 month study in 282 patients. J Geriatr Drug Ther 1991; 5(3):59 72.

70. *Cooper JW. Drug assessment in nursing home patients with renal impairment.J Geriatr Drug Ther 1991; 5(1):73 88.and J Pharmacoepidem. 1992;2(4):3-12.

71. * Mallet L, Cooper JW. Prolongation of prothrombin time with the use of piroxicam and warfarin. Can J Hosp Pharm 1991;44(2):93 4.

72. Cooper JW. Managing depression and depressive symptoms:a five-year study. Nurs Homes 1993; 42(2):37-39.

73. Cooper JW. ACEI Drug Interactions (case reports). Nurs Home Pract 1994;2(5):28-30.

74. * Cooper JW. Falls and fractures in nursing home patients receiving psychotropic drugs.Internat J Geriatr Psych 1994;9:975-80.

75. * Cooper JW. Pharmacotherapy Recommendations from Monthly Drug Regimen Reviews in a Geriatric Nursing Facility: A One-Year Study. Pharmacotherapy 1994; 13:687

76. * Cooper JW. Consultant pharmacist contribution to diabetes mellitus treatment outcomes in two patient outcomes in two nursing faciltites. Cons Pharm 1995;10(1):13-18.

77. * Cooper JW. Adverse drug reactions and interactions in a geriatric nursing home population over 4 years. J Am Geriatr Soc 1996; 44:194-197.

78. * Cooper JW. Falls in nursing home patients receiving classical antihistamines while stabilized on psychoactive medications, J Pharmacoepidem 1996; 5(1):45-50.

79. * Cooper JW. Health Care Costs and Outcomes from Consultant Pharmacist Recommendations in A Geriatric Nursing Facility: A One-year Study. J Geriatr Drug Ther 1997: 11(4):51-73.; also published as Cost-benefit analysis of consultant pharmacist recommendations from monthly drug regimen reviews in a geriatric nursing facility; a one-year study in J Pharmacoepidem 1997: 6(1): 23-36.

80. * Cooper JW. Geriatric drug therapy interventions. J Geriatr Drug Ther 1997; 11(4):3-26.

81. * Cooper JW. Geriatric drug therapy intervention failure and associated costs. J Geriatri Drug Ther 1997;11(4):65-70.

82. * Wade WE, Cooper JW. Bowel obstruction associated with fiber administration within an entire nursing facility population, J Geriatr Drug Ther 1997; 12 (1):94-94.

83. * Cooper JW, Wade WE. Repeated unnecessary NSAID-associated hospitalizations: a case report. J Geriatr Drug Ther 1997; 12 (1): 95-98.

84. * Wade WE, Cooper JW. Severe tardive dyskinesia and weight loss associated with metoclpropamide administration with haloperidol: a case report. J Geriatr Drug Ther 1997; 12 (1): 99-104.

85. * Cooper JW, Wade WE. Possible lower bowel perforation associated with ibuprofen administration: a case report. J Geriatr Drug Ther 1997; 12 (1): 105-108.

86. * Cooper JW. Consultant pharmacist effect on NSAID costs and gastropathy over a 5-year period. Consult Pharm 1997; 12:792-796.

87. * Cooper JW. Consultant pharmacist assessment and reduction of fall risk in nursing facilities. Consult Pharm 1997; 12: 1294-1304.

88. * Cooper JW. Consultant pharmacist assessment of fall injury incidence and costs within a nursing facility. Consult Pharm 1997; 12: 1305-1309.

89. * Cooper JW . Reducing falls among patients in nursing homes. JAMA 1997;278: 1742.

90. * Cooper JW. Consultant pharmacist drug therapy recommendations from monthly drug regimen reviews in a geriatric nursing facility: a two-year study and cost analysis. J Nutri Health and Aging 1997; 1(3): 181-184.

91. * McRae A, Cooper JW. Use of nonaggressive short-term nutritional supplementation in a skilled nursing facility. Consult Pharm 1998; 13:174-181.

92. * Beach JW, Cooper JW, Francisco GE, Langford A. An infectious disease course for an entry-level doctor of pharmacy program. Am J Pharm Ed 1998; 62(2): 296-301.

93. * Cooper JW. Fatal asymptomatic hypoglycemia in an elderly insulin-using diabetic patient, Diabetes Care 1998; 21(12):9-10.

94. * Cooper JW. Oral agent treatment of type 2 diabetes mellitus in older adults. Ann Long Term Care-Nursing Home Medicine 1998; 6: 414-422.

95. * Cooper JW. Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. Sou Med J 1999; 92:485-490.

96. * Cooper JW. Psychoactive drugs may have a role in pressure sore origin. Br Med J 2000; 321:452.

97. Cooper JW, Cobb HH, Burfield AH. A one year study of psychotropic load reduction and buspirone conversion possible effects on behavioral disturbances and global deterioration in a rural nursing home population, Cons Pharm 2001; 16(4):358-363.

98. Cooper JW, Horner MR. Psychotropic load and falls in nursing facility residents, in review. (nominated for ASHP Student Research Award for 2000)

99. Cooper JW. Drugs may have reduced effect of falls intervention. Br Med J 2001; 322:675.

100. Cooper JW. Reducing psychotropic drugs reduces falls in elderly people. Br Med J 2001; 323:402.

101. Fick DM, Cooper JW, Wade WE, Waller J, McLean R, Beers MH. Updating the Beer’s criteria for Potentially Inappropropriate Medication Use in Older Adults. Archives of Internal Medicine, 2003;163:2716-2724.

102. Cooper JW, Burfield AH. Anticholinergics to Avoid with Cholinesterase Inhibitors. Ann Long Term Care 2003; 4(11): 50-51.

103. Cooper JW, Burfield AH. Response to Anticholinergics to Avoid- Quarternary vs. Tertiary Ammonium Antimuscarinics, ibid, May, 2003.

104. Cooper JW. Pseudoephedrine adverse drug effects, Drug Topics 2004; 23;56.

105. Cooper JW., Wade WE. Pharmacists interventions in geriatric nursing facility-NSAID Therapy . Cons Pharm 2005; 20(6): 492-7.

106. Perri M, Menon AM, Desspande AD, Shinde SB, Jiang R, Cooper JW et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005; 39; 405-11.

107. Cooper JW, Burfield AH. Management of the cognitively impaired residents: a practical guide for long-term care. ElderCare 2005; 5(1):3-5.

108. Cooper JW, McCall CY, Marshburn RP, Burfield AH . A senior care clerkship for pharmacy students. Consult Pharm 2006;21:482-92.

109. Cooper JW, Burfield AH . Transitional care of elderly residents with anemia. ElderCare 2005; 6(2):1-5.

110. Cooper JW, Freeman MH, Cook CL, Burfield AH. Psychotropic and Psychoactive Drug Load Assessment and Falls in Nursing Facility Residents.Consult Pharm 2007:22:483-9.

111. Cooper JW, Freeman MH, Cook CL, Burfield AH. Psychotropic and Psychoactive Drugs and Hospitalization Rates in Nursing Facility Residents. Pharmacy Practice 2007;5(3):140-4.

112. Cooper JW, Wade WE, Cook CL, Burfield AH. Consultant Pharmacist Drug Therapy Recommendations Acceptance and Rejection from Monthly Drug Regimen Reviews in A Geriatric Nursing Facility: Fourth Year Results and Cost Analysis. Hosp Pharm 2007;42:729-36.